Cargando…
First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro
First- and second-generation antipsychotics (FGAs and SGAs, respectively), have the ability to inhibit cholesterol biosynthesis and also to interrupt the intracellular cholesterol trafficking, interfering with low-density lipoprotein (LDL)-derived cholesterol egress from late endosomes/lysosomes. In...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813259/ https://www.ncbi.nlm.nih.gov/pubmed/26999125 http://dx.doi.org/10.3390/ijms17030404 |
_version_ | 1782424277224521728 |
---|---|
author | Canfrán-Duque, Alberto Barrio, Luis C. Lerma, Milagros de la Peña, Gema Serna, Jorge Pastor, Oscar Lasunción, Miguel A. Busto, Rebeca |
author_facet | Canfrán-Duque, Alberto Barrio, Luis C. Lerma, Milagros de la Peña, Gema Serna, Jorge Pastor, Oscar Lasunción, Miguel A. Busto, Rebeca |
author_sort | Canfrán-Duque, Alberto |
collection | PubMed |
description | First- and second-generation antipsychotics (FGAs and SGAs, respectively), have the ability to inhibit cholesterol biosynthesis and also to interrupt the intracellular cholesterol trafficking, interfering with low-density lipoprotein (LDL)-derived cholesterol egress from late endosomes/lysosomes. In the present work, we examined the effects of FGA haloperidol on the functionality of late endosomes/lysosomes in vitro. In HepG2 hepatocarcinoma cells incubated in the presence of 1,1′-dioctadecyl-3,3,3,3′-tetramethylindocarbocyanineperchlorate (DiI)-LDL, treatment with haloperidol caused the enlargement of organelles positive for late endosome markers lysosome-associated membrane protein 2 (LAMP-2) and LBPA (lysobisphosphatidic acid), which also showed increased content of both free-cholesterol and DiI derived from LDL. This indicates the accumulation of LDL-lipids in the late endosomal/lysosomal compartment caused by haloperidol. In contrast, LDL traffic through early endosomes and the Golgi apparatus appeared to be unaffected by the antipsychotic as the distribution of both early endosome antigen 1 (EEA1) and coatomer subunit β (β-COP) were not perturbed. Notably, treatment with haloperidol significantly increased the lysosomal pH and decreased the activities of lysosomal protease and β-d-galactosidase in a dose-dependent manner. We conclude that the alkalinization of the lysosomes’ internal milieu induced by haloperidol affects lysosomal functionality. |
format | Online Article Text |
id | pubmed-4813259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-48132592016-04-06 First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro Canfrán-Duque, Alberto Barrio, Luis C. Lerma, Milagros de la Peña, Gema Serna, Jorge Pastor, Oscar Lasunción, Miguel A. Busto, Rebeca Int J Mol Sci Article First- and second-generation antipsychotics (FGAs and SGAs, respectively), have the ability to inhibit cholesterol biosynthesis and also to interrupt the intracellular cholesterol trafficking, interfering with low-density lipoprotein (LDL)-derived cholesterol egress from late endosomes/lysosomes. In the present work, we examined the effects of FGA haloperidol on the functionality of late endosomes/lysosomes in vitro. In HepG2 hepatocarcinoma cells incubated in the presence of 1,1′-dioctadecyl-3,3,3,3′-tetramethylindocarbocyanineperchlorate (DiI)-LDL, treatment with haloperidol caused the enlargement of organelles positive for late endosome markers lysosome-associated membrane protein 2 (LAMP-2) and LBPA (lysobisphosphatidic acid), which also showed increased content of both free-cholesterol and DiI derived from LDL. This indicates the accumulation of LDL-lipids in the late endosomal/lysosomal compartment caused by haloperidol. In contrast, LDL traffic through early endosomes and the Golgi apparatus appeared to be unaffected by the antipsychotic as the distribution of both early endosome antigen 1 (EEA1) and coatomer subunit β (β-COP) were not perturbed. Notably, treatment with haloperidol significantly increased the lysosomal pH and decreased the activities of lysosomal protease and β-d-galactosidase in a dose-dependent manner. We conclude that the alkalinization of the lysosomes’ internal milieu induced by haloperidol affects lysosomal functionality. MDPI 2016-03-18 /pmc/articles/PMC4813259/ /pubmed/26999125 http://dx.doi.org/10.3390/ijms17030404 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Canfrán-Duque, Alberto Barrio, Luis C. Lerma, Milagros de la Peña, Gema Serna, Jorge Pastor, Oscar Lasunción, Miguel A. Busto, Rebeca First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro |
title | First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro |
title_full | First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro |
title_fullStr | First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro |
title_full_unstemmed | First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro |
title_short | First-Generation Antipsychotic Haloperidol Alters the Functionality of the Late Endosomal/Lysosomal Compartment in Vitro |
title_sort | first-generation antipsychotic haloperidol alters the functionality of the late endosomal/lysosomal compartment in vitro |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813259/ https://www.ncbi.nlm.nih.gov/pubmed/26999125 http://dx.doi.org/10.3390/ijms17030404 |
work_keys_str_mv | AT canfranduquealberto firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT barrioluisc firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT lermamilagros firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT delapenagema firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT sernajorge firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT pastoroscar firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT lasuncionmiguela firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro AT bustorebeca firstgenerationantipsychotichaloperidolaltersthefunctionalityofthelateendosomallysosomalcompartmentinvitro |